STEVEN GIRGENTI - 31 Jan 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Executive Chairman, Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Steven Girgenti
Issuer symbol
BIAF
Transactions as of
31 Jan 2024
Net transactions value
$0
Form type
4
Filing time
02 Feb 2024, 16:20:17 UTC
Previous filing
24 Jan 2024
Next filing
29 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +11,943 +1.3% $0.000000 952,284 31 Jan 2024 Direct F1
holding BIAF Common Stock 8,955 31 Jan 2024 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.
F2 These shares owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.